TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04423588

Dexlansoprazole Absorption and Marginal Ulceration After Gastric Bypass

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“No participants enrolled.”

The sponsor’s own words in the registry.

Life of this trial

20202021202220232024202520262027Registered2020-02-07Planned start2022-01-01 (planned)Withdrawn (as of)2026-06-09

Vital statistics

Status
Withdrawn
Phase
Phase 4
Sponsor
Spital Limmattal Schlieren
Sponsor type
University, hospital or other
Conditions
Bariatric Surgery
Interventions
dexlansoprazole serum concentration; upper endoscopy
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.